HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angela Esposito Selected Research

Breast Neoplasms (Breast Cancer)

1/2022Evolution of low HER2 expression between early and advanced-stage breast cancer.
1/2019A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer.
12/2017Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer.
8/2017Entinostat for the treatment of breast cancer.
5/2017Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer.
1/2017Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial.
11/2016Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer.
11/2015Targeting fibroblast growth factor receptor pathway in breast cancer.
5/2015Neoadjuvant Model for Testing Emerging Targeted Therapies in Breast Cancer.
1/2015Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angela Esposito Research Topics

Disease

25Neoplasms (Cancer)
11/2021 - 10/2012
22Breast Neoplasms (Breast Cancer)
01/2022 - 01/2008
3Melanoma (Melanoma, Malignant)
11/2020 - 08/2013
3Triple Negative Breast Neoplasms
08/2017 - 09/2014
3Disease Progression
06/2014 - 09/2012
3Neoplasm Metastasis (Metastasis)
06/2014 - 01/2008
2Circulating Neoplastic Cells
01/2017 - 10/2010
1COVID-19
11/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
1Retinoblastoma (Glioblastoma, Retinal)
05/2017
1Lung Neoplasms (Lung Cancer)
01/2017
1Cachexia
11/2015
1Testicular Neoplasms (Testicular Cancer)
11/2015
1Anorexia
11/2015
1Sudden Death
03/2015
1Torsades de Pointes (Torsade de Pointes)
03/2015
1Osteolysis
02/2015
1Bone Resorption
02/2015
1Prostatic Neoplasms (Prostate Cancer)
08/2013
1Cardiovascular Diseases (Cardiovascular Disease)
11/2012

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
7Hormones (Hormone)IBA
08/2017 - 02/2013
5Estrogen ReceptorsIBA
02/2014 - 01/2008
4AntigensIBA
11/2015 - 10/2010
4Phenobarbital (Luminal)FDA Link
05/2015 - 10/2012
3Immune Checkpoint InhibitorsIBA
11/2020 - 03/2014
3Pharmaceutical PreparationsIBA
05/2017 - 05/2014
3Circulating Tumor DNAIBA
01/2017 - 06/2014
3Neoplasm Antigens (Tumor Antigens)IBA
11/2015 - 08/2013
3Biological ProductsIBA
06/2014 - 10/2012
2human ERBB2 proteinIBA
01/2022 - 01/2014
2Trastuzumab (Herceptin)FDA Link
01/2019 - 11/2012
2DNA (Deoxyribonucleic Acid)IBA
08/2017 - 01/2016
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 09/2012
2AntibodiesIBA
02/2014 - 08/2013
2Cancer VaccinesIBA
02/2014 - 08/2013
2VaccinesIBA
01/2014 - 08/2013
2Progesterone Receptors (Progesterone Receptor)IBA
01/2014 - 10/2012
1mRNA VaccinesIBA
11/2021
1COVID-19 VaccinesIBA
11/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2020
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2019
1TOR Serine-Threonine KinasesIBA
09/2019
1ErbB Receptors (EGF Receptor)IBA
12/2017
1Estrogen Receptor Modulators (Antiestrogen)IBA
08/2017
1Proteins (Proteins, Gene)FDA Link
08/2017
1benzamideIBA
08/2017
1Histone Deacetylases (Histone Deacetylase)IBA
08/2017
1Histones (Histone)IBA
08/2017
1entinostat (MS 275)IBA
08/2017
1Cyclin DIBA
05/2017
1ribociclibIBA
05/2017
1Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2017
1Capecitabine (Xeloda)FDA Link
01/2017
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2017
1anamorelinIBA
11/2015
1Differentiation AntigensIBA
11/2015
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
11/2015
1ChemokinesIBA
11/2015
1Ghrelin ReceptorsIBA
11/2015
1E-3810IBA
11/2015
1LigandsIBA
02/2015
1DenosumabFDA Link
02/2015
1Diphosphonates (Bisphosphonates)IBA
02/2015
1Cytotoxins (Cytolysins)IBA
09/2014
1dinaciclibIBA
09/2014
1Cell-Free Nucleic AcidsIBA
06/2014
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2014
1Tyrosine Kinase InhibitorsIBA
05/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2014
1Phosphotransferases (Kinase)IBA
05/2014
1IpilimumabIBA
08/2013
1Monoclonal AntibodiesIBA
08/2013
1Immunologic Factors (Immunomodulators)IBA
08/2013
1sipuleucel-T (APC8015)FDA Link
08/2013
1thiamine triphosphorate (TTP)IBA
11/2012
1Epidermal Growth Factor (EGF)IBA
10/2012
1Fulvestrant (Faslodex)FDA Link
09/2012
1Methotrexate (Mexate)FDA LinkGeneric
09/2012
1Taxoids (Taxanes)IBA
01/2008
1AnthracyclinesIBA
01/2008
1taxaneIBA
01/2008

Therapy/Procedure

17Therapeutics
11/2021 - 11/2012
8Drug Therapy (Chemotherapy)
01/2019 - 07/2010
6Immunotherapy
11/2021 - 08/2013
3Adjuvant Chemotherapy
09/2014 - 01/2008
2Cell- and Tissue-Based Therapy (Cell Therapy)
02/2014 - 08/2013
1Precision Medicine
01/2016
1Radiotherapy
11/2015